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OsteopontinSummary Gestational alloimmune liver disease (GALD) produces severe neonatal liver disease that is notable
for paucity of hepatocytes, large numbers of parenchymal tubules, and extensive fibrosis. Liver specimens from
19GALD cases were studied in comparisonwith 14 infants without liver disease (normal newborn liver; NNL)
to better understand the pathophysiology that would produce this characteristic histopathology. GALD liver
parenchyma contained large numbers of tubules comprising epithelium expressing KRT7/19, EPCAM, and
SOX9, suggesting biliary progenitor status. Quantitative morphometry demonstrated that in GALD, the area
density of KRT19+ tubules was 16.4 ± 6.2 versus 2.0 ± 2.6 area% in NNL (P b .0001). Functional hepatocyte
masswasmarkedly reduced inGALD, 16.3 ± 6.2 versus 61.9 ± 11.0 area%ofCPS1+ cells inNNL (Pb .0001).
A strong inverse correlation was established between CPS1+ area density and KRT19+ area density (r2 = 0.66,
Pb .0001). Tubules showed active hedgehog signaling as determined bySHHandnuclearGLI2 expression and
expressed the profibrogenic cytokine SPP1. SPP1 protein content and SPP1 expression were greater in GALD
than NNL (15- and 13-fold respectively; P = .002). GALD liver contained large numbers of activated
myofibroblasts and showed greater than 10-fold more fibrosis than NNL. The extent of fibrosis correlated with
the area density of KRT19+ tubules (r2 = 0.387, P = .001). The data support a pathogenic model in which
immune injury to fetal hepatocytes provides a stimulus for expansion of parenchymal tubules, which, byway of
Hh activation, produce fibrogenic signals leading to vibrant fibrosis.
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Severe fibrotic liver disease in the newborn indicates the
onset of liver injury during fetal life. Such disease has been
called “congenital cirrhosis” and has been associated with the
neonatal hemochromatosis phenotype, wherein there are iron
overload and tissue siderosis in a pattern similar to that seen iness article under the CC BY-NC-ND license (http://creativecommons.org/
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fetal liver injury leading to congenital cirrhosis and the neonatal
hemochromatosis phenotype is gestational alloimmune liver
disease (GALD) [2]. GALD-related alloimmunity is specifi-
cally directed at fetal hepatocytes. No nonhepatocyte elements
in the liver appear to be injured, and tissues outside the liver
appear to be unaffected by the primary immune process. The
mechanism of alloantibody-induced hepatocyte injury appears
to involve the fetal innate immune system. The terminal
complement cascade is activated by the classical pathway and
results in the formation of membrane attack complex.
Immunohistochemical staining for C5b-9 complex (the
neoantigen created during terminal complement cascade
activation and culmination with formation of membrane attack
complex) shows nearly all hepatocytes in cases of GALD to
have complement-mediated injury [3]. The immediate result of
such injurymay be liver failure in the fetus andmay lead to fetal
death [4]. However, in most cases, the process moves more
slowly, starting inmidgestation and resulting in liver failure and
often cirrhosis by term [2,5]. Newborns with GALD typically
show clinical liver failure usually within the first days of life.
The immune injury in GALD is specifically directed at
hepatocytes and results in liver disease confined to the lobule.
The liver histopathology includes severe depletion of hepato-
cytes relative to normal newborn liver (NNL) [5]. Remaining
hepatocytes appear as giant cells and pseudoacini, which are
constructs of hepatocytes surrounding a central space often
containing bile. Another epithelial structure appears in abun-
dance in the livers of GALD cases: namely, tubular forms,
which consist of epithelial cells surrounding a narrow central
lumen that is usually devoid of bile. They are usually narrow and
elongated in contrast to the generally round pseudoacini. They
are morphologically similar to the “ductular reaction” observed
in humans with massive and submassive necrosis associated
with acute liver failure [6,7]. It is thought that this represents a
regenerative effort and that the ductules may be derived from
stem cells residing in the canals of Hering and/or ductal plate
remnants [7]. Further expansion of regenerative elements results
in the “ductular reaction” in which neoductules (also known as
neocholangioles) expressing biliary progenitor markers extend
from the ductal plate/canals of Hering into the lobule. Biliary
atresia and other cholestatic liver diseases of infancy are notable
for “ductular reaction” along the limiting plate of the portal triad.
In the case of biliary atresia, it appears that a repair response to
biliary injury leads to a hyperactive hedgehog (Hh)–driven
regenerative signal with resultant biliary dysmorphogenesis [8].
The liver histopathology inGALDand biliary atresia are in stark
contrast; however, the 2 diseases are similar in that they exhibit
extensive fibrosis very early in life.
In GALD, fibrosis is in the lobule, whereas in biliary atresia,
it is portal. Tubules that appear throughout the lobule in GALD
share several morphologic features, with reactive ductules
appearing along the limiting plate in biliary atresia. In addition,
GALD is a disease of the fetal liver wherein Hh and other
developmental pathways are maximally active. We hypothe-
sized that formation of parenchymal tubules drives the lobularfibrogenesis inGALD, in analogy to the role of reactive ductules
in portal fibrogenesis in biliary atresia [8,9]. Hence, we
examined the relationships among tubule formation,Hh activity,
osteopontin production, myofibroblast expansion and activa-
tion, and fibrosis in GALD. The results suggest that expanded
formation of tubules is likely central to lobular fibrogenesis in
GALD and that active Hh signaling by tubules is involved.2. Materials and methods
2.1. Cases and reference materials
GALD cases: liver specimens from 19 GALD cases were
included in the study. The subjects of this study were newborns
with liver failure and the NH phenotype. All 19 liver specimens
showed evidence of complement-mediated hepatocyte damage
andwere among cases previously reported [3]. Their postpartum
ages ranged from 1 to 12 weeks. Of these, 14 specimens were
collected by autopsy and 5 were hepatic explants. All 19
specimens were used for histology and immunohistochemistry
studies, whereas the 5 hepatic explants were in addition snap-
frozen at the time of harvest and processed for RNA and protein
expression analyses. Reference cases (referred to as NNL
throughout) comprised the following. Liver specimens from 8
newborns who died from perinatal asphyxia were obtained at
autopsy. These cases showed no histologic liver damage and
have been similarly used in other published studies [3,5,10].
Liver specimens from 6 children aged 4 months to 5 years were
snap-frozen at harvest and processed for RNA and protein
analysis. These cases included 4 deceased organ donors, 1 infant
undergoing laparotomy, and the disease-free liver of 1 child
undergoing hepatoblastoma resection. The specimens all
showed normal histology and have been used for gene and
protein expression analyses in comparison with neonatal and
infant liver disease in other published studies [8,10]. This study
was approved by the institutional review board of Lurie
Children's Hospital of Chicago.
2.2. Molecular techniques
The expressions of the various genes listed in the Table
were determined using real-time reverse transcription poly-
merase chain reaction, as previously described [8,10]. The
detailed methods and primer sequences used are presented in
Supplementary Table S1. The expression of each gene was
normalized to the expression of GAPDH in each sample. The
results for individual genes are listed according to how they
appear in the following results and will be presented as
supporting evidence for the other studies performed. The
expressions of genes relative to GAPDH in GALD liver and
NNL are provided in Supplementary Table S2. In the Table,
the normalized expression of each gene in GALD and NNL
was computed as the fold-expression relative to the median
expression in the NNL cohort. The statistical significance of
Table Expressions of genes relevant to cell lineage, Hh
pathway, and fibrogenesis determined by RT-PCR in GALD
liver expressed as fold-difference from NNL
Gene
symbol
Description Fold difference
NNL, mean
(range)
Wilcoxon
P value
KRT7 Keratin 7 9.7 (2.2-30.8) .004
KRT19 Keratin 19 16.6 (3.8-28) .002
CPS1 Carbamoyl-phosphate
synthase 1
0.7 (0.02-2.1) NS ⁎
EPCAM Epithelial cell adhesion
molecule
50.1 (29.4-68.5) .002
SOX9 SRY (sex determining
region Y)-box 9
8.9 (2.6-19.0) .002
SHH Sonic Hh 2.1 (0.6-6.5) NS ⁎
GLI1 GLI family zinc finger 1 3.5 (0.8-8.4) NS ⁎
GLI2 GLI family zinc finger 2 8.1 (4.4-18.4) .002
GLI3 GLI family zinc finger 3 7.7 (1.1-23.0) .024
PTCH1 Patched 1 1.6 (0.6-4.1) NS ⁎
HHIP Hh interacting protein 4.2 (1.9-10.9) .041
SMO Smoothened 0.6 (0.1-1.5) NS ⁎
SPP1 Secreted
phosphoprotein 1 (also
known as osteopontin)
13.3 (4.2-24.4) .002
S100A4 Fibroblast specific
protein 1
1.1 (0.3-1.6) NS ⁎
ACTA2 α-Smooth muscle actin
(also known as α-SMA)
8.2 (3.2-14.0) .002
GFAP Glial fibrillary acidic
protein
0.5 (0.03-1.0) NS ⁎
DES Desmin 15.5 (6.8-26.6) .002
ELN Elastin 24.4 (7.1-57.9) .002
COL1A1 Collagen, type I, alpha 1 26.1 (5.3-75.7) .041
COL3A1 Collagen, type III, alpha 1 7.5 (2.7-14.0) .006
COL4A2 Collagen, type IV, alpha 2 13.7 (7.7-26.2) .002
COL5A1 Collagen, type V, alpha 1 10.7 (3.2-28.3) .006
Abbreviation: RT-PCR, reverse transcription polymerase chain
reaction.
⁎ NS, Not significant, P N .05.
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by Wilcoxon test.
2.3. Histology, immunohistochemistry, and
quantitative morphometry
Immunohistochemistry was used to characterize cell
lineage, to localize cells that produce Hh pathway factors,
and to demonstrate complement-mediated hepatocyte damage
as described [3,8]. The methodology and antibodies used are
provided in Supplementary Table S3. To determine area
density of cell types expressing various markers, immunohis-
tochemically stained liver sections were analyzed using a
point-counting method as previously described [5]. To
quantify tissue fibrosis, area density of fibrosis and collage-
nous fiber was measured in picro Sirius Red (PSR)–stainedliver sections using computerized quantitative morphometry.
Details are provided in the supplementary information.
2.4. Measurement of SPP1 (also known as
osteopontin) protein concentration
Liver SPP1 concentration was measured by immunoassay
using electrochemiluminescence detection technology
(Meso Scale Discovery, Gaithersburg, MD) according to
the manufacturer's instructions. Published work shows that
this immunoassay system provides precise measurement of
SPP1 at low concentration in small biological samples [11].
We validated the assay characteristics with recombinant
SPP1 and found the precise range of measurement to extend
from 0.066 to 200 ng/well (r2 = 0.999). Measurements were
made in triplicate for each sample.3. Results
3.1. Characterization of tubular epithelial lineage
and the relationship between the densities of
tubules and hepatocytes
Immunohistochemical phenotyping with various lineage
markers was performed to characterize tubules. KRT7 and
KRT19 were strongly and evenly expressed in tubules
distributed throughout the lobule (Fig. 1A). These markers
of biliary epithelial lineage are expressed on biliary progenitors
during development and regeneration [12] as well as mature
bile ducts. Hepatocyte forms (multinucleated giant cells and
pseudoacini) were negative for both markers. In contrast, in
NNL, these markers were expressed in interlobular bile ducts,
epithelium at the limiting plate of portal areas and canals of
Hering (Fig. 1A, inset). Quantitative morphometry showed a
marked increase in KRT19+ cell area density relative to NNL:
GALD KRT19+ area density (n = 16) was 16.4 ± 6.2 area%
versus 2.0 ± 2.6 area% in NNL (n = 8; P b .0001). KRT7
expression was 9.7-fold greater in GALD than NNL, and
KRT19 expression was 16.6-fold greater (Table).
The urea cycle enzyme CPS1 is expressed in the liver by
functional hepatocytes [13]. In specimens from GALD, CPS1
localizedmainly to hepatocyte forms (Fig. 1B). Hepatocytes in
NNL showed uniform CPS1 positivity (Fig. 1B, inset).
Quantitative morphometry showed a marked reduction in
functioning hepatocytes in GALD cases: GALD cases (n = 16)
had 16.3 ± 6.2 area% of CPS1+ cells versus 61.9 ± 11.0 area%
in NNL (n = 8; P b .0001). An inverse correlation was
established between CPS1+ area density and KRT19+ area
density in newborn liver, including GALD and NNL (Fig. 1C).
Liver sections were further studied by immunohisto-
chemistry for expression of epithelial cell adhesion molecule
(EPCAM), which is expressed on biliary epithelial stem cells
and progenitors [12,14,15] and the foregut-derived–stem cell
transcription factor SOX9 [15–17]. In GALD, epithelial cells
Fig. 1 Lineage markers expressed by epithelium of lobular tubules in GALD suggests that they are biliary progenitors. A, Tubules strongly
expressed KRT19. Inset, KRT19 expression in NNL is limited to ductal plate and canals of Hering. B, Only occasional epithelial cells in
tubules expressed the hepatocyte marker CPS1. Inset, uniform CPS1 expression in hepatocytes of NNL. C, In this set of newborn livers,
including GALD and NNL, area density of CPS1+ cells inversely correlated with that of KRT19+ cells: r2 = 0.66, P b .0001. D, Epithelial
cells in tubules stained for EPCAM. Inset, biliary EPCAM expression in NNL. E, Most epithelial cells in tubules stained for SOX9. Inset,
interlobular bile duct SOX9 expression in NNL. All images acquired at ×200 magnification.
87Lobular tubules and fibrosis in GALDin tubules uniformly expressed EPCAM (Fig. 1D) and most
expressed SOX9 (Fig. 1E). Hepatocyte forms were negative
for EPCAM and SOX9. In NNL, ductal plate epithelial cells
expressed both EPCAM and SOX9, and interlobular bile
ducts expressed SOX9 (insets of Fig. 1D and E). EPCAM
expression in GALD liver was 50-fold greater than that in
NNL, and SOX9 expression was 8.9-fold greater (Table).
These findings further suggest that the plentiful tubules
spread throughout the lobule in GALD liver are potentially
progenitors designated for elaboration of biliary epithelium
and hepatocytes.
3.2. Hh pathway and SPP1 production in tubules
In order to determine if tubules in GALD exhibit Hh
signaling, we examined liver specimens from GALD for
expression of molecules related to the Hh signaling pathway.
Most tubules in GALD specimens strongly expressed Hhligand sonic (SHH) by immunohistochemistry (Fig. 2A),
whereas SHH could not be detected in hepatocyte forms or
other elements of the liver. Scant SHHexpressionwas detected
in NNL, mainly in cells along the limiting plate of some portal
tracts (Fig. 2A, inset). In order to determinewhat cellsmight be
responding to the SHH signal, livers were examined for
expression of the Hh-responsive gene product, nuclear
transcription factor for Hh signal activation glioblastoma-2
(GLI2). Nuclear staining for GLI2 provides evidence for Hh
response [18] and was seen prominently in the epithelial cells
of tubules (Fig. 2B). Nuclear GLI2 expression could not be
detected in NNL. Double staining for EPCAM and GLI2
confirmed that epithelial cells constituting tubules are Hh
responsive (Fig. 2C). The results of gene expression assays
(Table) show variable expressions of Hh pathway–related
genes. GLI2, GLI3, and HHIP were significantly over-
expressed relative to NNL, whereas SHH, GLI1, PTCH1,
and SMO were not. These results are not surprising as the
Fig. 2 Tubules in GALD produce Hh ligand, show Hh responsiveness, and produce Hh response product. A, Tubules express SHH. Inset, faint
SHH expression by periportal hepatocytes and epithelial cells along the limiting plate in NNL. B, Tubules showHh responsiveness, as demonstrated
by positive GLI2 staining of most epithelial nuclei. C, Double staining for GLI2 (brown) and EPCAM (blue-green) demonstrates tubules are Hh-
responsive.D, Tubules are themain site of SPP1 expression inGALD liver. E, NNL shows SPP1 expression by epithelial cells along the limiting plate
and interlobular bile ducts. F,When analyzed by immunoassay in snap-frozen liver, SPP1 concentration is significantly higher in GALD (n = 5) than
in NNL (n = 6): Wilcoxon test, P = .002. Data are displayed as box-and-whisker plot.
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pathway is highly active in development [8]. The location of
the activity as indicated by immunohistochemistry clearly
separates GALD from NNL. In sum, these findings indicate
that the epithelium of parenchymal tubules is Hh responsive as
well as producing SHH.
SPP1 (also known as osteopontin) is a potent profibro-
genic cytokine and a known target gene of the Hh pathway
[19]. In GALD specimens, only tubules strongly expressed
SPP1 (Fig. 2D). The location of SPP1 staining was consistent
with its production by epithelial cells, and in addition, its
accumulation within the lumens of tubules suggests that they
also secrete SPP1. Scant SPP1 expression was seen in ductal
plate cells and interlobular bile ducts in NNL (Fig. 2E). In
order to determine the magnitude of SPP1 production in
GALD relative to NNL, we measured liver SPP1 protein
concentration. GALD liver showed 15-fold greater SPP1
protein content than NNL (Fig. 2F). Similarly, SPP1
expression was 13.3-fold greater in GALD than in NNL
(Table). In summary, hepatic SPP1 production (expression) is
markedly increased in GALD liver, and parenchymal tubules
appear to be responsible for its hyperproduction.3.3. Phenotype of fibrosis-related cells in
GALD liver
Expansion of the mesenchymal cell compartment is an
important feature of fibrotic liver. We examined GALD livers
by immunohistochemistry for expression of fibroblast-specific
protein 1 (FSP1; also known as S100A4), a marker for
fibroblastic transformation [20]. Large numbers of S100A4+
cells with fibroblast-like morphologywere found in the stroma
surrounding tubules, but the epithelium of tubules did not
express S100A4 (Fig. 3A). To gain greater granularity of the
relationship between tubules and S100A4+ stromal cells, we
performed double stainingwithKRT7 and S100A4. The stains
did not colocalize to a single cell type: epithelial cells of
tubules were KRT7+, whereas S100A4+ cells closely abutted
tubules but did not overlay them (Fig. 3B). This confirmed
exclusive localization of S100A4 to fibroblasts and not to
tubule epithelium. In order to determine if S100A4+
fibroblasts were responsive to Hh signals, double staining for
GLI2 and S100A4was performed. Some S100A4+ fibroblasts
harbored GLI2-positive nuclei, indicating their Hh responsive
status (Fig. 3C).
Fig. 3 Increased fibroblasts and myofibroblasts in GALD. A, Staining for S100A4 (also known as FSP1) localized to interstitial cells, but
not to tubules. B, Double staining for KRT7 (brown) and S100A4 (blue-green) demonstrates that cells showing this fibroblast marker surround
and closely approximate tubule epithelium. C, Double staining for GLI2 (brown) and S100A4 (blue-green) shows that most Hh-responsive
cells are epithelial, but some fibroblasts (arrows) also show nuclear GLI2. D, E, and F, Serial sections from the same specimen. D, Staining for
α-SMA (also known as ACTA2) is extensive in interstitium surrounding tubules and intense in the wall of an artery in the portal area (upper
right). Inset, delicate α-SMA staining of sinusoidal endothelial cells and intense staining of an artery (right) in NNL. E, DES+ myofibroblasts
are scattered in the lobule, whereas the portal area (upper right) shows no positivity other than in the arterial wall. Inset, DES+ portal blood
vessels in NNL. F, ELN+myofibroblasts densely populate the interstitium surrounding tubules and portal area stroma (upper right). Inset, ELN
staining of portal stroma in NNL.
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we performed immunohistochemistry on GALD liver speci-
mens for α-smooth muscle actin (α-SMA; also known as
ACTA2), a marker for activated myofibroblasts [21]; glial
fibrillary acidic protein (GFAP), a marker for quiescent hepatic
stellate cells (HSCs) [22]; desmin (DES), a marker for activated
HSCs [23]; and elastin (ELN), a marker for portal fibroblasts
[21,24]. α-SMA+ cells were observed throughout lobular
stroma, but not in tubules and not in the stroma of the portal triad
(Fig. 3D). NNL showed delicate α-SMA staining of sinusoidal
endothelial cells and intense staining in walls of arteries
(Fig. 3D, inset). No GFAP+ cells were identified in GALD
specimens, whereas scattered GFAP+ cells were identified in
the lobule in NNL (data not shown). Scattered DES+ cells were
seen in the lobule in GALD specimens, but not in the stroma of
the portal triad (Fig. 3E). NNL showed no DES positivity other
than in thewalls of portal blood vessels (Fig. 3E, inset). The area
occupied by DES+ cells was a small fraction of that staining for
α-SMA.ExtensiveELN stainingwas seen in lobular stroma and
throughout the stroma of portal triads in GALD liver (Fig. 3F),
whereas staining was seen only in the stroma of portal areas in
NNL (Fig. 3F, inset). In support of these findings, GFAPexpression was not increased in GALD relative to NNL,
whereas ACTA2, DES, and ELN were all several-fold over-
expressed (Table). Altogether these findings indicate a marked
increase in myofibroblasts in GALD liver. The extensive ELN
staining coincided with that for α-SMA. The extent of ELN
staining relative to DES suggests that the increased population
of myofibroblasts arose through expansion of the pool of
designated portal fibroblasts rather than from HSCs.
3.4. The amount of fibrosis in GALD and its
relationship to tubule density
Computerized morphometry was performed on PSR-stained
liver sections to quantitate total fibrosis and collagen area
density. GALD cases showed diffuse fibrosis throughout the
liver lobule (Fig. 4A), whichwhen observedwith polarized light
showed yellow-green birefringence characteristic of organized
collagen (Fig. 4B). NNL showed fibrosis and organized
collagen only in portal areas (Fig. 4C and D). The fibrosis
area density, measured by image analysis of PSR-stained liver
sections photographed in bright field, was 35.6 ± 13.4 area%
in GALD (n = 17) versus 2.7 ± 1.3 area% in NNL (n = 9;
Fig. 4 Extensive lobular fibrosis and collagen deposition in GALD. A, PSR-stained GALD specimen shows extensive fibrosis (red)
throughout the lobule, whereas the portal area (P, lower left) shows minimal fibrotic expansion. B, The same specimen shows extensive cross-
linked collagen coinciding with the fibrosis (green-yellow). C and D, NNL shows fibrosis and collagen only in the portal area. E and F,
Computerized morphometry performed on the liver from GALD cases (n = 19) shows an excess of fibrosis and collagen relative to NNL (n =
8). Data are displayed as box-and-whisker plot; Wilcoxon for GALD versus NNL, P b .0001 for both fibrosis and collagen.
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analysis of images obtainedwith polarized light, was 16.1 ± 5.7
area% inGALD (n = 19) versus 1.4 ± 0.7 area% inNNL (n = 9;
P b .0001; Fig. 4F). Genes related to collagen formation in
human liver disease were all several-fold overexpressed in
GALD liver relative to NNL: COL1A1, 26-fold; COL3A1,
7.5-fold; COL4A2, 13.7-fold; and COL5A1, 10.7-fold (Table).
In sum, these data show increased fibrogenesis and extensive
lobular fibrosis and collagen deposition in GALD.
Among GALD subjects, some have fewer hepatocyte
forms and more tubules, whereas others have morehepatocyte forms and fewer tubules (Fig. 1C). Observation
suggested that specimens with relatively more tubules had
greater fibrosis than those with relatively more hepatocyte
forms (Fig. 5). To evaluate this potential relationship, we
performed linear correlation analysis between the area
density KRT19+ cells and the area density of fibrosis and
collagen. KRT19+ cell area density correlated well with the
extent of both total fibrosis (Fig. 5E) and collagen (Fig. 5F).
In summation of the foregoing data, lobular fibrosis and
collagen deposition are markedly increased in GALD liver
and correlate with the density of KRT19+ tubules.
Fig. 5 The degree of fibrosis and collagen deposition correlates with the density of tubules. A and B, Images from a representative GALD
case show few CPS+ hepatocyte forms and extensive KRT19+ tubules (brown), with extensive fibrosis (red). C and D, Images from a
representative GALD case show more CPS+ hepatocyte forms and fewer KRT19+ tubules, with less extensive fibrosis. E and F, Computerized
morphometry performed in a sample set of newborn livers containing GALD (n = 16) and NL (n = 8) shows a positive correlation between
KRT19+ (tubule) area density and fibrosis area density (r2 = 0.387, P = .001) and collagen area density (r2 = 0.343, P = .003).
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This study of GALD provides evidence for a novel
mechanism of fibrogenesis in which hyperactive develop-
mental pathways play a significant if not singular role in the
evolution of liver lobular fibrosis. Liver injury in GALD is
mediated by maternally derived IgG and fetal complement, is
directed specifically at hepatocytes, and results in dramatic
hepatocyte injury and loss. In order for the fetus to survive,effort is required to replace lost and damaged hepatocytes
and maintain some critical level of liver function. This effort
appears to engage foregut-derived stem cells and results in
extensive elaboration of tubules expressing KRT7/19,
EPCAM and SOX9 throughout the lobule. These tubules
exhibit active Hh signaling and produce SPP1 in excess. The
data suggest that Hh signaling constitutes an important
mechanism in the repair process in response to hepatocyte
injury in GALD. However, an untoward effect of excessive
92 A. Asai et al.Hh-pathway activation results, namely, extensive interstitial
fibrosis. The data suggest that Hh signaling may mediate the
expansion of the mesenchymal compartment comprising
myofibroblasts and the massive increase in fibrosis seen in
GALD. Thus, the data suggest that in GALD, regeneration
and lobular fibrosis are linked, at least partially through Hh.
Our results provide evidence for a pathway for aberrant
lobular tubulogenesis in GALD that could only occur in
developing liver. Expression of SOX9, EPCAM, and KRT7/19
by epithelium of tubules suggests that they comprise foregut-
derived biliary progenitors [17,25]. However, their uniform
distribution throughout the lobule is quite different from the
periportal ductular reaction seen in massive hepatic necrosis in
mature liver [6]. At midgestation in normal human embryonic
development, biliary progenitors may be seen in the lobule
admixed with hepatoblasts [26]. In mature liver undergoing
injury, regeneration requires recruitment of stem cells from
limited rests in the ductal plate, whereas in developing liver,
interruption of hepatocyte maturation as seen in C/EBPalpha
(Cebpa)-knockout mice results in expansion of progenitors
located in the lobule [27,28]. There is no understanding of how
achievement of a full complement of hepatocytes feeds back on
the system to limit their further production. The inverse
relationship between the density of KRT19+ tubules and that of
hepatocytes in GALD liver suggests that loss of hepatocytes
prompts regeneration leading to a markedly expanded
progenitor compartment in the location normally occupied by
hepatocytes in developing liver.
The findings in this study provide evidence that aberrant
developmental signaling and extensive elaboration of tubules
in GALD create an environment conducive to lobular
fibrogenesis. Expansion of progenitors in Cebpa knockout
mice is associated with fibrosis [27]. The strong correlation
between the area density of tubules and the extent of fibrosis
in GALD liver suggests a similar relationship. The
connective tissue surrounding tubules in GALD liver is
densely occupied by activated myofibroblasts. The origin of
the myofibroblasts cannot be determined from the data. ELN
staining coinciding with extensive α-SMA staining suggests
lineage similar to portal fibroblasts. S100A4+ fibroblasts that
closely surround tubules are Hh responsive and potentially
are receiving stimulus from SHH elaborated by epithelial
cells in tubules. Tubules appear to be the source of the
markedly increased expression of the profibrogenic cytokine
SPP1 observed in GALD. A binding element for the Hh
pathway transcription factor GLI1 in its promoter induces
greater SPP1 expression with activation of Hh signaling
[19,29]. Our data show active Hh signaling and SPP1
expression to be colocalized to tubules. Hh-induced SPP1
expression has been shown to contribute to lobular fibrosis in
experimental and human nonalcoholic liver disease [30,31]
and alcoholic liver disease [32–35]. In addition, it has been
suggested that SOX9 directly regulates SPP1 expression in
HSCs and that Hh acts through SOX9 to promote fibrosis
[36]. However, in our studies, SOX9 and SPP1 expression
localized to tubules, and neither was observed in mesenchy-mal cells. Nevertheless, the possibility exists that Hh
regulates SPP1 expression in tubules both via GLI1 and
SOX9 pathways. Furthermore, Hh signal may directly
influence myofibroblastic transformation of HSCs [37,38],
and excessive SOX9 expression in fetal hepatocytes may
mediate ectopic extracellular matrix deposition characteristic
of fibrosis by way of HSC transformation [39]. Thus, there
appear to be multiple tubule-associated signal pathways in
GALD that could contribute to fibrosis associated with
expanded numbers of parenchymal tubules: Hh-driven SPP1
production, SOX9-driven SPP1 production, Hh-driven
myofibroblastic transformation of HSCs, and SOX9-driven
ectopic extracellular matrix deposition via HSC transforma-
tion. The relative contributions of these mechanisms cannot
be determined from the data.
In summary, the results of this study provide evidence for a
novel model of pathogenesis in GALD wherein injury to fetal
hepatocytes leads to tubulogenesis and fibrosis. This patho-
physiologic process occurs in the background of developing
liver and represents chronic liver disease of the fetus. Beginning
around midgestation and extending to term, immune injury to
hepatocytes precludes normal lobular development, which
promotes expansion of tubules and in turn promotes fibrogen-
esis. The process culminates in the unique liver pathology
associated with neonatal hemochromatosis.Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.humpath.2014.09.010.References
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